Technology
Health
Biotechnology

Cellectar Biosciences

1,427

$1.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.07 (+5.22%) Today
+$0.04 (+2.84%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell CLRB and other stocks, options, ETFs, and crypto commission-free!

About CLRB

Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro metastatic disease; CLR 124 which could detects tumors and metastases in a broad range of cancers; and CLR 1502, a cancer-targeting near-infrared-fluorophore optical imaging PDC for intraoperative tumor and tumor margin illumination. Read More The company was founded in June 1996 and is headquartered in Florham Park, NJ.

CEO
James V. Caruso
Employees
8
Headquarters
Florham Park, New Jersey
Founded
1996
Market Cap
33.84M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
893.79K
High Today
$1.48
Low Today
$1.38
Open Price
$1.38
Volume
1.09M
52 Week High
$3.33
52 Week Low
$1.01

Collections

Technology
Health
Biotechnology
Cancer Prevention
Medical
2018 IPO
US
North America

CLRB News

BenzingaJul 1

Why Cellectar Biosciences Stock Is Trading Higher Today

Cellectar Biosciences (NASDAQ: CLRB) shares are trading higher on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and $5 p
0

CLRB Earnings

-$0.76
-$0.49
-$0.21
$0.06
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Estimated
— per share
Actual
Expected Aug 12, Pre-Market

You May Also Like

MET-A
TILT
CURE
OCSI
NM
LRN
FVAC
DGP
CNSP
FEAC=
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy CLRB

Market Price$1.45
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell CLRB stock and options commission-free.
LearnBlogCareersHelpLog InSign Up